INSIGHTS ON DRUG DEVELOPMENT

DRUG DEVELOPMENT SOLUTIONS

  • Waters series of chromatography columns and standards offer scientists the diverse range of chromatographic selectivities needed to help characterize today's biotherapeutics and biosimilars.

  • Explore how key biomarkers like Amyloid-beta, TAU, and α-Synuclein are transforming neurodegeneration research, with enhanced detection strategies that improve diagnostic accuracy.

  • Early manufacturability assessments, complete cGMP solutions, and everything in between. FUJIFILM Diosynth Biotechnologies is a leading provider of cell culture services for biologics, advancing and delivering life-changing therapies.

  • Over the course of 30+ years we’ve invested in and developed a broad range of expertise, a full suite of lab and analytical services, advanced technology platforms and a world-class facilities network.

  • Cambrex’s understanding of crystal formation and thermodynamics allows us to develop custom, scalable crystallization processes for peptides. We leverage the right tools with the best experts to bridge success from the bench to the plant.